As of the close on March 21, 2024, CymaBay Therapeutics, Inc.'s stock has gained approximately 266.18% over the past 52 weeks. The 50-day moving average sits at 27.84, while the 200-day moving average is 17.70.
| 52-Week Price Change | 266.18% |
| 50-Day Moving Average | 27.84 |
| 200-Day Moving Average | 17.70 |